05/28/2026
The Strategic API Reserve underscores a critical reality: resilient, domestic pharmaceutical supply chains are no longer optional. But true resilience requires more than stockpiles — it demands logistics expertise, trusted partner networks, and systems built to perform under pressure.
At Callan JMB, we’ve spent decades building those capabilities. This is not a strategic pivot; it is the result of years of investment and foresight in anticipation of exactly this moment. By aligning with evolving national priorities, we help our clients remain not only compliant but also competitive in a rapidly changing market.
www.callanjmb.com/green-solutions